参考文献/References:
[1] 权学莲,徐秀芹,刘春霞,等.扶正清髓汤治疗BCR/ABL阴性的骨髓增殖性肿瘤疗效观察[J].陕西中医,2014,35(7):865-866.
[2] Nangalia J,Green AR.Myeloproliferative neoplasms:from origins to outcomes[J].Blood,2017,130(23):2475-2483.
[3] Chuzi S,Stein BL.Essential thrombocythemia:a review of the clinical features,diagnostic challenges,and treatment modalities in the era of molecular discovery[J].Leuk Lymphoma,2017,58(12):2786-2798.
[4] Tefferi A,Barbui T.Polycythemia vera and essential thrombocythemia:2017 update on diagnosis,risk-stratification,and management[J].Am J Hematol,2017,92(1):94-108.
[5] Nagashima T,Harada S,Kimura H.Takotsubo cardiomyopathy developing during anagrelide therapy in a patient with essential thrombocythemia[J].Rinsho Ketsueki,2018,59(12):2606-2608.
[6] 中华医学会血液学分会白血病淋巴瘤学组.原发性血小板增多症诊断与治疗中国专家共识(2016年版)[J].中华血液学杂志,2016,37(10):833-836.
[7] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002:173-177.
[8] 田林涛,王宗超,梁 漫,等.CD34+细胞在原发性骨髓纤维化症和原发性血小板增多症骨髓组织中的表达[J].陕西医学杂志,2014,43(6):648-649,666.
[9] 张津京,李 艳,颜晓菁.骨髓增生异常/骨髓增殖性肿瘤伴环形铁粒幼细胞和血小板增多一例报告并文献复习[J].中华肿瘤防治杂志,2020,27(1):71-74.
[10] 王雪梅,汤久慧,王茂生,等.参芪杀白汤为主联合化疗治疗急性白血病合并脾周围炎临床研究[J].陕西中医,2020,41(2):202-205.
[11] 陆小华,马 骁,王 建,等.赤芍的化学成分和药理作用研究进展[J].中草药,2015,46(4):595-602.
[12] 刘丹丹,戴 娜,范婧莹,等.白花蛇舌草抗肿瘤药理研究[J].中医药导报,2009,15(9):64-67.
[13] 叶未央,李 祥,陈建伟,等.板蓝根清热解毒作用机制的研究进展[J].中医药导报,2010,16(12):107-110.
[14] Tantry US,Gurbel PA.A bigger look into the “therapeutic window” of platelet reactivity to adenosine diphosphate[J].JACC Cardiovasc Interv,2015,8(15):1988-1989.
[15] 吕艳艳,薛阳利,陶美花,等.黄芩苷联合干扰素α治疗乙型肝炎肝纤维化临床研究[J].陕西医学杂志,2018,47(5):643-645.
[16] Lekovi D,Goti M,Ljubi A.First successful pregnancy outcome after intrauterine insemination in a woman with primary infertility and essential thrombocythemia treated with interferon-alpha and aspirin[J].Srp Arh Celok Lek,2015,143(34):210-213.
[17] 权学莲,赵宏伟,范海燕,等.疏肝化瘀汤治疗气滞血瘀型原发性血小板增多症[J].中医学报,2019,34(1):172-176.
[18] 赵建君,杨 娇,李 果,等.活血化瘀中药治疗衰竭期慢性肾衰竭患者疗效观察[J].陕西中医,2018,39(1):80-82.